| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 329.73B | 339.23B | 344.60B | 314.31B | 236.50B | 209.42B |
| Gross Profit | 33.84B | 34.24B | 33.14B | 27.78B | 24.11B | 20.07B |
| EBITDA | 35.12B | 37.43B | 38.68B | 30.25B | 28.30B | 27.77B |
| Net Income | 11.26B | 12.44B | 13.24B | 10.27B | 8.88B | 6.53B |
Balance Sheet | ||||||
| Total Assets | 325.15B | 321.39B | 304.13B | 288.70B | 282.54B | 237.96B |
| Cash, Cash Equivalents and Short-Term Investments | 42.65B | 43.00B | 44.58B | 44.23B | 40.69B | 29.16B |
| Total Debt | 50.72B | 50.32B | 40.41B | 51.88B | 64.12B | 46.38B |
| Total Liabilities | 113.45B | 109.03B | 98.73B | 112.00B | 118.61B | 92.90B |
| Stockholders Equity | 197.36B | 198.00B | 191.67B | 164.69B | 152.29B | 133.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.15B | 13.89B | 20.00B | -3.53B | 5.55B |
| Operating Cash Flow | 0.00 | 22.54B | 37.46B | 37.27B | 14.06B | 25.12B |
| Investing Cash Flow | 0.00 | -30.05B | -30.89B | -16.02B | -18.86B | -15.53B |
| Financing Cash Flow | 0.00 | 5.77B | -16.38B | -17.58B | 12.55B | -17.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥82.03B | 7.82 | ― | 4.95% | -5.89% | 8.95% | |
79 Outperform | ¥76.37B | 7.83 | 5.20% | 3.67% | -3.78% | -16.61% | |
78 Outperform | ¥217.13B | 6.43 | 13.11% | 2.87% | 3.95% | 136.86% | |
71 Outperform | ¥70.37B | 3.21 | ― | 3.66% | -6.79% | 303.74% | |
68 Neutral | ¥180.74B | -8.32 | ― | 1.93% | -3.23% | 24.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥214.80B | 16.01 | ― | 4.77% | -3.71% | -51.81% |